GUTS Q4 2022 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

GUTSFractyl Health, Inc. Common Stock

$35M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$11M

Net Income

-$11M

EPS (Diluted)

$-0.23

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$907,000

Balance Sheet

Total Assets

$61M

Total Liabilities

$313M

Stockholders' Equity

-$252M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$11M	-$12M	+4.7%
Net Income	-$11M	-$13M	+13.3%